Report cover image

Global Pre-Exposure Prophylaxis (PrEP) Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 198 Pages
SKU # APRC20277719

Description

Summary

According to APO Research, The global Pre-Exposure Prophylaxis (PrEP) market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pre-Exposure Prophylaxis (PrEP) is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pre-Exposure Prophylaxis (PrEP) include Amneal Pharmaceuticals, Aurobindo Pharma, Gilead Sciences, Mylan, Teva, ViiV Healthcare, Zydus, Anhui Baker Biopharmaceutical and Chengdu Brilliant Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pre-Exposure Prophylaxis (PrEP), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pre-Exposure Prophylaxis (PrEP), also provides the sales of main regions and countries. Of the upcoming market potential for Pre-Exposure Prophylaxis (PrEP), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pre-Exposure Prophylaxis (PrEP) sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pre-Exposure Prophylaxis (PrEP) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pre-Exposure Prophylaxis (PrEP) sales, projected growth trends, production technology, application and end-user industry.

Pre-Exposure Prophylaxis (PrEP) Segment by Company

Amneal Pharmaceuticals
Aurobindo Pharma
Gilead Sciences
Mylan
Teva
ViiV Healthcare
Zydus
Anhui Baker Biopharmaceutical
Chengdu Brilliant Pharmaceutical
North China Pharmaceutical
Qilu Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Pre-Exposure Prophylaxis (PrEP) Segment by Type

Oral PrEP
Injectable PrEP
Pre-Exposure Prophylaxis (PrEP) Segment by Application

Hospital and Clinic
Pharmacy
Other
Pre-Exposure Prophylaxis (PrEP) Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Exposure Prophylaxis (PrEP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pre-Exposure Prophylaxis (PrEP) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Exposure Prophylaxis (PrEP).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pre-Exposure Prophylaxis (PrEP) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pre-Exposure Prophylaxis (PrEP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pre-Exposure Prophylaxis (PrEP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pre-Exposure Prophylaxis (PrEP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Pre-Exposure Prophylaxis (PrEP) Market Size, 2020 VS 2024 VS 2031
1.3 Global Pre-Exposure Prophylaxis (PrEP) Market Size Estimates and Forecasts (2020-2031)
1.4 Global Pre-Exposure Prophylaxis (PrEP) Sales Estimates and Forecasts (2020-2031)
1.5 Global Pre-Exposure Prophylaxis (PrEP) Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Pre-Exposure Prophylaxis (PrEP) Market Dynamics
2.1 Pre-Exposure Prophylaxis (PrEP) Industry Trends
2.2 Pre-Exposure Prophylaxis (PrEP) Industry Drivers
2.3 Pre-Exposure Prophylaxis (PrEP) Industry Opportunities and Challenges
2.4 Pre-Exposure Prophylaxis (PrEP) Industry Restraints
3 Pre-Exposure Prophylaxis (PrEP) Market by Manufacturers
3.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Manufacturers (2020-2025)
3.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Manufacturers (2020-2025)
3.3 Global Pre-Exposure Prophylaxis (PrEP) Average Sales Price by Manufacturers (2020-2025)
3.4 Global Pre-Exposure Prophylaxis (PrEP) Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pre-Exposure Prophylaxis (PrEP) Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers, Product Type & Application
3.7 Global Pre-Exposure Prophylaxis (PrEP) Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Pre-Exposure Prophylaxis (PrEP) Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pre-Exposure Prophylaxis (PrEP) Players Market Share by Revenue in 2024
3.8.3 2024 Pre-Exposure Prophylaxis (PrEP) Tier 1, Tier 2, and Tier 3
4 Pre-Exposure Prophylaxis (PrEP) Market by Type
4.1 Pre-Exposure Prophylaxis (PrEP) Type Introduction
4.1.1 Oral PrEP
4.1.2 Injectable PrEP
4.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type
4.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Type (2020-2031)
4.2.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Type (2020-2031)
4.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type
4.3.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Type (2020-2031)
4.3.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Type (2020-2031)
5 Pre-Exposure Prophylaxis (PrEP) Market by Application
5.1 Pre-Exposure Prophylaxis (PrEP) Application Introduction
5.1.1 Hospital and Clinic
5.1.2 Pharmacy
5.1.3 Other
5.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application
5.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Application (2020-2031)
5.2.3 Global Pre-Exposure Prophylaxis (PrEP) Sales Market Share by Application (2020-2031)
5.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application
5.3.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Application (2020-2031)
5.3.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Application (2020-2031)
6 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region
6.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2020-2031)
6.2.1 Global Pre-Exposure Prophylaxis (PrEP) Sales by Region (2020-2025)
6.2.2 Global Pre-Exposure Prophylaxis (PrEP) Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Pre-Exposure Prophylaxis (PrEP) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Pre-Exposure Prophylaxis (PrEP) Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Pre-Exposure Prophylaxis (PrEP) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Pre-Exposure Prophylaxis (PrEP) Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Pre-Exposure Prophylaxis (PrEP) Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region
7.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region
7.1.1 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2020-2025)
7.1.3 Global Pre-Exposure Prophylaxis (PrEP) Revenue by Region (2026-2031)
7.1.4 Global Pre-Exposure Prophylaxis (PrEP) Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Pre-Exposure Prophylaxis (PrEP) Revenue (2020-2031)
7.2.2 North America Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Pre-Exposure Prophylaxis (PrEP) Revenue (2020-2031)
7.3.2 Europe Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Pre-Exposure Prophylaxis (PrEP) Revenue (2020-2031)
7.4.2 Asia-Pacific Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Pre-Exposure Prophylaxis (PrEP) Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Amneal Pharmaceuticals
8.1.1 Amneal Pharmaceuticals Comapny Information
8.1.2 Amneal Pharmaceuticals Business Overview
8.1.3 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Amneal Pharmaceuticals Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.1.5 Amneal Pharmaceuticals Recent Developments
8.2 Aurobindo Pharma
8.2.1 Aurobindo Pharma Comapny Information
8.2.2 Aurobindo Pharma Business Overview
8.2.3 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Aurobindo Pharma Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.2.5 Aurobindo Pharma Recent Developments
8.3 Gilead Sciences
8.3.1 Gilead Sciences Comapny Information
8.3.2 Gilead Sciences Business Overview
8.3.3 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Gilead Sciences Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.3.5 Gilead Sciences Recent Developments
8.4 Mylan
8.4.1 Mylan Comapny Information
8.4.2 Mylan Business Overview
8.4.3 Mylan Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Mylan Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.4.5 Mylan Recent Developments
8.5 Teva
8.5.1 Teva Comapny Information
8.5.2 Teva Business Overview
8.5.3 Teva Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Teva Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.5.5 Teva Recent Developments
8.6 ViiV Healthcare
8.6.1 ViiV Healthcare Comapny Information
8.6.2 ViiV Healthcare Business Overview
8.6.3 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 ViiV Healthcare Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.6.5 ViiV Healthcare Recent Developments
8.7 Zydus
8.7.1 Zydus Comapny Information
8.7.2 Zydus Business Overview
8.7.3 Zydus Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Zydus Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.7.5 Zydus Recent Developments
8.8 Anhui Baker Biopharmaceutical
8.8.1 Anhui Baker Biopharmaceutical Comapny Information
8.8.2 Anhui Baker Biopharmaceutical Business Overview
8.8.3 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Anhui Baker Biopharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.8.5 Anhui Baker Biopharmaceutical Recent Developments
8.9 Chengdu Brilliant Pharmaceutical
8.9.1 Chengdu Brilliant Pharmaceutical Comapny Information
8.9.2 Chengdu Brilliant Pharmaceutical Business Overview
8.9.3 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Chengdu Brilliant Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.9.5 Chengdu Brilliant Pharmaceutical Recent Developments
8.10 North China Pharmaceutical
8.10.1 North China Pharmaceutical Comapny Information
8.10.2 North China Pharmaceutical Business Overview
8.10.3 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 North China Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.10.5 North China Pharmaceutical Recent Developments
8.11 Qilu Pharmaceutical
8.11.1 Qilu Pharmaceutical Comapny Information
8.11.2 Qilu Pharmaceutical Business Overview
8.11.3 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Qilu Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.11.5 Qilu Pharmaceutical Recent Developments
8.12 Chia Tai Tianqing Pharmaceutical
8.12.1 Chia Tai Tianqing Pharmaceutical Comapny Information
8.12.2 Chia Tai Tianqing Pharmaceutical Business Overview
8.12.3 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Chia Tai Tianqing Pharmaceutical Pre-Exposure Prophylaxis (PrEP) Product Portfolio
8.12.5 Chia Tai Tianqing Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Pre-Exposure Prophylaxis (PrEP) Value Chain Analysis
9.1.1 Pre-Exposure Prophylaxis (PrEP) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pre-Exposure Prophylaxis (PrEP) Production Mode & Process
9.2 Pre-Exposure Prophylaxis (PrEP) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pre-Exposure Prophylaxis (PrEP) Distributors
9.2.3 Pre-Exposure Prophylaxis (PrEP) Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.